{"id":"W2911614100","doi":"10.1161/circulationaha.118.035864","title":"Stroke Outcomes in the COMPASS Trial","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute","funders":"Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Boston Scientific Corporation; Eisai; Boston VA Research Institute; GlaxoSmithKline; Bayer; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Daiichi Sankyo Europe; Sanofi; American Heart Association","keywords":"Medicine; Aspirin; Rivaroxaban; Stroke (engine); Internal medicine; Hazard ratio; Modified Rankin Scale; Coronary artery disease; Intracerebral hemorrhage; Warfarin; Randomized controlled trial; Anesthesia; Cardiology; Surgery; Atrial fibrillation; Confidence interval; Ischemic stroke; Subarachnoid hemorrhage","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002266906,0.0008211131,0.00155559,0.0004475897,0.0002971879,0.001080811,0.0004839039,0.0007531942,0.003729502],"category_scores_gemma":[0.003135845,0.000210245,0.001402068,0.000809285,0.0004196269,0.0004436515,0.0007388818,0.001064453,0.0004609775],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004974285,"about_ca_system_score_gemma":0.00124213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001394531,"about_ca_topic_score_gemma":0.002786348,"domain_scores_codex":[0.9985153,0.0007482667,0.0001234516,0.0002183473,0.000266523,0.0001280674],"domain_scores_gemma":[0.9983163,0.000224288,0.0007186169,0.0001097369,0.0001989845,0.000432124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6543062,0.002037592,0.1739402,0.006458586,0.02878809,0.000702358,0.0002801129,0.001573487,0.002323701,0.001880165,0.03285138,0.09485807],"study_design_scores_gemma":[0.45351,0.03990698,0.4580713,0.00201888,0.01407603,0.001412485,0.0002320534,0.001368354,0.0009495693,0.002774059,0.02555876,0.0001215224],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9482048,0.03113473,0.0004350222,0.003628254,0.0006894038,0.0007587048,0.006371645,0.00008083829,0.008696523],"genre_scores_gemma":[0.9771573,0.007247999,0.0008733868,0.002648715,0.001362642,0.001332586,0.006985149,0.00002187735,0.002370356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003729502,"threshold_uncertainty_score":0.01247638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07464536859794811,"score_gpt":0.3447212517401188,"score_spread":0.2700758831421706,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}